FAQ

What is energeyes?
energeyes is a lightweight, wearable vision aid developed by Electronic Eyewear Solutions. Designed for individuals with low vision caused by macular degeneration, glaucoma, diabetic retinopathy, and other conditions, energeyes uses advanced electronic eyewear technology to enhance sight and restore independence in daily life.

How does it work?
energeyes combines four key features in one device:

  • Magnification to make text and objects clearer.

  • Contrast adjustment to sharpen visibility in difficult lighting.

  • Color inversion (black-to-white or white-to-black) for improved readability.

  • Brightness control to adapt to different environments and reduce eye strain.

Who can benefit from energeyes?
energeyes is ideal for individuals with vision loss that cannot be fully corrected by glasses, contact lenses, or surgery. It is especially useful for those living with age-related macular degeneration, diabetic eye disease, glaucoma, or general low vision due to aging.

How is energeyes different from other low vision aids?
Unlike bulky magnifiers or expensive alternatives that can cost over $5,000, Energeyes is portable, stylish, and more affordable. It requires no medical training to use and is designed for comfort, ease of use, and everyday practicality.

Can I use energeyes while walking or driving?
energeyes is designed primarily for seated or stationary activities such as reading, watching TV, using a computer, or enjoying family time. It is not intended for driving or navigation in unfamiliar environments.

Where can I purchase energeyes?
energeyes will be available through participating eye care providers (ophthalmologists, optometrists, and low-vision clinics) as well as direct-to-consumer sales. Financing options will be available to improve affordability.

How much does energeyes cost?
energeyes is expected to retail at less than half the price of leading competitors like eSight—making high-quality low vision innovation accessible to more people.

Is energeyes FDA-approved?
energeyes is classified as an assistive technology device. While it does not require FDA approval as a medical treatment, it has undergone user trials to validate its safety and effectiveness.

Is this an investment opportunity?
Yes. energeyes is also a medical device startup seeking strategic investors to scale production and distribution. With patents, a rapidly growing low vision market, and strong demand driven by an aging population, energeyes represents a unique accredited investor opportunity in healthcare technology.

How can I learn more?
Patients can explore product details on our website, sign up for our email list below, or email us for more information. Investors can reach out to our team for pitch materials, financials, and partnership opportunities.